Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension
Pinto, J.M.
East African Medical Journal 58(1): 44-50
1981
ISSN/ISBN: 0012-835X PMID: 7011783 Document Number: 5279
A clinical trial with a combination of spironolactone and Thiazide Diuretic (aldactacine) was conducted to control essential hypertension in the African. The results proved that this combination was effective with minimum side effects.
Document emailed within 1 workday
Related Documents
Rhomberg, F. 1977: Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension Schweizerische Medizinische Wochenschrift 107(35): 1228-1232Mauro, B.; Savagnone, E. 1979: The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(2): 189-196
Bhalla, K.K. 1981: Evaluation of the effect of indapamide on moderate benign essential hypertension complicated by airways obstruction Postgraduate Medical Journal 57(Suppl 2): 34-36
Kreeft, J.H.; Larochelle, P.; Ogilvie, R.I. 1983: Comparison of chlorthalidone and spironolactone in low--renin essential hypertension Canadian Medical Association Journal 128(1): 31-34
Orabona, M.L.; Maiorano, G.; Loiacono, N. 1975: Spironolactone in essential hypertension. Controlled study on the dose-response relationship Minerva Cardioangiologica 23(12): 866-870
Di Veroli, C.; Compagno, S.; Iugoli, A.R. 1982: Spironolactone and propranolol in combination therapy of arterial hypertension La Clinica Terapeutica 103(3): 283-287
Tosti-Croce, C.; Mantellini, R.; Fanti, P.; Sciarra, F. 1983: Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension Minerva Medica 74(14-15): 791-797
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Mitrovic, V.; Patyna, W.; von Bruchhausen, V.; Schlepper, M. 1991: Nifedipine-clonidine combination in essential hypertension. Hemodynamic and neurohumoral findings of the combination in comparison with the effect of the individual substances Fortschritte der Medizin 109(32): 663-666
Torma, Z. 1984: Experiences with Chlortalidone treatment in benign essential hypertension cases Therapia Hungarica 32(2): 79-81
Kida, O.; Eto, T. 1992: Japanese clinical statistical data of patients with benign essential hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 221-227
Bolzano, K.; Krempler, F.; Sandhofer, F. 1984: A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension Acta Medica Austriaca 11(2): 49-53
Kirchner, D.; Wiedersberg, H. 1970: Clinical evaluation of renal hypertension in comparison to essential hypertension Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 25(19): 874-878
Sokolova, L.A.; Bondarenko, B.B.; Evdokimova, T.A. 1992: Comparative evaluation of cardiovascular system reactivity in patients with borderline arterial hypertension and the early stages of essential hypertension Fiziologiia Cheloveka 18(1): 128-135
Schwartz, F.N.; Tiffany, J. 1981: Timolol maleate and hydrochlorothiazide in control of essential hypertension: use of a fixed combination for once-a-day administration Journal of the American Osteopathic Association 80(9): 590-594
Forattini, C.; Perin, S. 1988: Combination captopril-hydrochlorothiazide in a single dose for treatment of essential arterial hypertension Rivista Europea Per le Scienze Mediche e Farmacologiche 10(1): 63-67
Salvadeo, A.; Villa, G.; Segagni, S.; Moroni, G.; Poggio, F. 1988: Validity of a fixed atenolol/hydrochlorothiazide/amiloride combination (100/25/2.5 mg) in the therapy of essential arterial hypertension Minerva Cardioangiologica 36(3): 109-113
Minami, J.; Ishimitsu, T.; Matsuoka, H. 2005: Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension Nihon Jinzo Gakkai Shi 47(8): 864-869
Jones, D.W.; Sands, C.D. 1991: Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide PharmacoTherapy 11(2): 127-130
Chanudet, X.; De Champvallins, M. 2001: Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension International Journal of Clinical Practice 55(4): 233-239